Princeton startup SpliceBio Announces First Patient Dosed in Phase 1/2 ASTRA Study of SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
Introducing The Engine's Blueprint Program | Deadline To Apply This Friday! Read more about Introducing The Engine's Blueprint Program | Deadline To Apply This Friday!
Princeton-led technology for room-temperature vaccines and biological drugs selected as finalist in Science Center QED research accelerator program
